preclinical study Erlotinib exhibits antineoplastic off-target effects in AML and MDS: a

2008 
    • Correction
    • Cite
    • Save
    • Machine Reading By IdeaReader
    30
    References
    0
    Citations
    NaN
    KQI
    []